Literature DB >> 20594232

Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life.

Makiko Kaji1, Yasuhiro Fujiwara, Masatsugu Shiba, Yukie Kohata, Hirokazu Yamagami, Tetsuya Tanigawa, Kenji Watanabe, Toshio Watanabe, Kazunari Tominaga, Tetsuo Arakawa.   

Abstract

OBJECTIVE: Gastroesophageal reflux disease (GERD), functional dyspepsia (FD), and irritable bowel syndrome (IBS) are common, and have negative impacts on health-related quality of life (HR-QOL). Several studies demonstrated a significant overlap between two of these three diseases. The purpose of this study was to examine the prevalence of GERD, FD, and IBS, their overlap rates, and HR-QOL for each disease and each overlap compared with healthy controls in the Japanese general population.
METHODS: We performed a cross-sectional study of Japanese workers who visited a clinic for a routine health check-up, and asked them to fill out a self-report questionnaire. Prevalence and overlap rate of GERD defined as heartburn and/or acid regurgitation at least weekly, FD and IBS based on Rome III criteria, and HR-QOL by SF-8 were examined.
RESULTS: Of the 2680 eligible subjects, 207 (7.7%) were diagnosed as having GERD, 269 (10.0%) as FD, and 381 (14.2%) as IBS. Overlaps were found in 46.9% in GERD, 47.6% in FD, and 34.4% in IBS. Prevalence of overlaps in subjects with IBS was significantly lower compared with those among GERD or FD. Sufferers from GERD, FD, or IBS reported significantly poorer HR-QOL across all domains compared with controls. Overlaps significantly worsened HR-QOL in most domains except in the 'role emotional' domain. HR-QOL was particularly poor in the physical component summary for overlapping GERD and in the mental component summary for overlapping IBS.
CONCLUSION: Overlaps among GERD, FD and IBS were common and worsened HR-QOL in Japanese general population.

Entities:  

Mesh:

Year:  2010        PMID: 20594232     DOI: 10.1111/j.1440-1746.2010.06249.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  92 in total

1.  Comparison of presentation and impact on quality of life of gastroesophageal reflux disease between young and old adults in a Chinese population.

Authors:  Shou-Wu Lee; Chia-Ming Chang; Chi-Sen Chang; Ai-Wen Kao; Ming-Chih Chou
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

2.  Overlap syndrome of functional dyspepsia and irritable bowel syndrome - are both diseases mutually exclusive?

Authors:  Hidekazu Suzuki; Toshifumi Hibi
Journal:  J Neurogastroenterol Motil       Date:  2011-10-31       Impact factor: 4.924

3.  A double-blind placebo controlled study of acotiamide hydrochloride for efficacy on gastrointestinal motility of patients with functional dyspepsia.

Authors:  Kumiko Nakamura; Toshihiko Tomita; Tadayuki Oshima; Haruki Asano; Takahisa Yamasaki; Takuya Okugawa; Takashi Kondo; Tomoaki Kono; Katsuyuki Tozawa; Yoshio Ohda; Hirokazu Fukui; Fukushima Kazuhito; Shozo Hirota; Jiro Watari; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2016-09-17       Impact factor: 7.527

4.  Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan.

Authors:  Masayoshi Ono; Mototsugu Kato; Shuichi Miyamoto; Momoko Tsuda; Takeshi Mizushima; Shouko Ono; Manabu Nakagawa; Katsuhiro Mabe; Soichi Nakagawa; Shuichi Muto; Yuichi Shimizu; Mineo Kudo; Shinichi Katsuki; Takashi Meguro; Naoya Sakamoto
Journal:  J Gastroenterol       Date:  2018-01-05       Impact factor: 7.527

5.  Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia.

Authors:  Yoshikazu Kinoshita; Hiroto Miwa; Katsuyuki Sanada; Koji Miyata; Ken Haruma
Journal:  J Gastroenterol       Date:  2013-05-08       Impact factor: 7.527

Review 6.  Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome.

Authors:  Nicola de Bortoli; Irene Martinucci; Massimo Bellini; Edoardo Savarino; Vincenzo Savarino; Corrado Blandizzi; Santino Marchi
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

7.  The challenges of evolving Rome criteria for functional dyspepsia.

Authors:  Craig A Friesen; Jennifer V Schurman
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-14

Review 8.  Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.

Authors:  Nicholas J Talley; Gerald Holtmann; Marjorie M Walker
Journal:  J Gastroenterol       Date:  2015-04-29       Impact factor: 7.527

9.  The current prevalence of irritable bowel syndrome in Asia.

Authors:  Full-Young Chang; Ching-Liang Lu; Tseng-Shing Chen
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

Review 10.  Review of antireflux procedures for proton pump inhibitor nonresponsive gastroesophageal reflux disease.

Authors:  L Hillman; R Yadlapati; M Whitsett; A J Thuluvath; M A Berendsen; J E Pandolfino
Journal:  Dis Esophagus       Date:  2017-09-01       Impact factor: 3.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.